Contineum Therapeutics, Inc. (CTNM)

Last Year

23-Nov-23 -- 22-Nov-24

Time Period:

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Other

Other

Insider Trading Sentiment: Accumulate

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

1

0

2

+1

0

+2

0

+3

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
11-Apr-24 6:10 PM View:	09-Apr-24 Conversion 0	Versant Venture Capital Vi,... 10% Owner		Contineum Therapeutics, Inc. - CTNM	144% 375.54K to 918.16K	0	0	--	--	Show Txns Hide Txns

20-Nov-24 5:07 PM View:	18-Nov-24 Sale (Planned) ($101.42K)	Lorrain Daniel S. Chief Scientific Officer		Contineum Therapeutics, Inc. - CTNM	(3%) 179.66K to 173.47K	0	0	--	--	Show Txns Hide Txns

14-Aug-24 6:03 PM View:	13-Aug-24 Option Exercise $12.93K	Huhn Stephen L. CMO & Sr VP, Clinical Dev.		Contineum Therapeutics, Inc. - CTNM	100% 0 to 12.8K	0	0	--	--	Show Txns Hide Txns